HEADER TOXIN 27-AUG-21 7RZ3 TITLE THE SOLUTION STRUCTURE OF REMIPEDE DOUBLE-ICK TOXIN PHI-XIBALBIN3-XT3A COMPND MOL_ID: 1; COMPND 2 MOLECULE: XT3A; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: XIBALBANUS TULUMENSIS; SOURCE 3 ORGANISM_TAXID: 1519145; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TOXIN, DOUBLE INHIBITOR, CYSTINE KNOT, RYANODINE RECEPTOR, MODULATOR EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR M.MAXWELL,Y.K.CHIN,M.MOBLI REVDAT 3 16-OCT-24 7RZ3 1 REMARK REVDAT 2 08-MAR-23 7RZ3 1 JRNL REVDAT 1 31-AUG-22 7RZ3 0 JRNL AUTH M.J.MAXWELL,C.THEKKEDAM,C.LAMBOLEY,Y.K.CHIN,T.CRAWFORD, JRNL AUTH 2 J.J.SMITH,J.LIU,X.JIA,I.VETTER,D.R.LAVER,B.S.LAUNIKONIS, JRNL AUTH 3 A.DULHUNTY,E.A.B.UNDHEIM,M.MOBLI JRNL TITL A BIVALENT REMIPEDE TOXIN PROMOTES CALCIUM RELEASE VIA JRNL TITL 2 RYANODINE RECEPTOR ACTIVATION. JRNL REF NAT COMMUN V. 14 1036 2023 JRNL REFN ESSN 2041-1723 JRNL PMID 36823422 JRNL DOI 10.1038/S41467-023-36579-W REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7RZ3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 30-AUG-21. REMARK 100 THE DEPOSITION ID IS D_1000259290. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : 20 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 500 UM [U-13C; U-15N] XT3A, 20 REMARK 210 MM SODIUM PHOSPHATE, 10 UM DSS, REMARK 210 0.02 % SODIUM AZIDE, 95% H2O/5% REMARK 210 D2O; 190 UM [U-13C; U-15N] XT3A, REMARK 210 20 MM SODIUM PHOSPHATE, 10 UM REMARK 210 DSS, 0.02 % SODIUM AZIDE, 95% REMARK 210 H2O/5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 3D 1H-13C NOESY ALIPHATIC; 3D 1H- REMARK 210 13C NOESY AROMATIC; 3D 1H-15N REMARK 210 NOESY; 3D CBCA(CO)NH; 3D HCACO; REMARK 210 3D HNCACB; 3D HNCO; 3D HBHA(CO) REMARK 210 NH; 2D CB(CGCC-TOCSY)HARO REMARK 210 SPECTROMETER FIELD STRENGTH : 900 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE NEO REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : TOPSPIN, ROWLAND NMR TOOLKIT REMARK 210 (RNMRTK), CCPNMR ANALYSIS, TALOS- REMARK 210 N, CYANA REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 30 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 LYS A 11 174.79 -55.17 REMARK 500 1 TYR A 37 -43.16 -131.85 REMARK 500 1 ASN A 38 -177.65 -68.95 REMARK 500 1 TYR A 42 52.07 -91.44 REMARK 500 1 HIS A 75 70.91 -154.75 REMARK 500 2 LYS A 11 173.33 -53.93 REMARK 500 2 CYS A 29 170.07 -51.56 REMARK 500 2 CYS A 34 88.57 -67.30 REMARK 500 2 HIS A 75 78.49 -158.79 REMARK 500 3 LYS A 11 174.77 -56.04 REMARK 500 3 HIS A 75 73.10 -156.89 REMARK 500 4 LYS A 11 174.71 -54.37 REMARK 500 4 CYS A 29 171.30 -52.29 REMARK 500 4 LYS A 36 54.31 -90.66 REMARK 500 4 HIS A 75 75.11 -156.88 REMARK 500 5 LYS A 11 174.77 -55.13 REMARK 500 5 LYS A 36 36.05 -95.80 REMARK 500 5 ASN A 38 134.26 -179.26 REMARK 500 5 TYR A 42 61.50 -112.30 REMARK 500 5 HIS A 75 74.11 -157.10 REMARK 500 6 LYS A 11 174.32 -54.61 REMARK 500 6 CYS A 34 98.87 -67.28 REMARK 500 6 LYS A 36 103.32 -51.52 REMARK 500 6 HIS A 75 75.49 -157.58 REMARK 500 7 TYR A 37 170.33 -57.86 REMARK 500 7 HIS A 75 72.97 -155.96 REMARK 500 8 LYS A 11 174.73 -56.29 REMARK 500 8 ARG A 35 -61.83 -128.99 REMARK 500 8 TYR A 42 -74.27 -103.27 REMARK 500 8 HIS A 75 74.41 -158.01 REMARK 500 9 TYR A 37 103.56 -51.51 REMARK 500 9 ASN A 38 -168.18 -67.49 REMARK 500 9 HIS A 75 71.31 -155.82 REMARK 500 10 TYR A 42 46.44 -91.52 REMARK 500 10 HIS A 75 75.05 -162.85 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30944 RELATED DB: BMRB REMARK 900 THE SOLUTION STRUCTURE OF REMIPEDE DOUBLE-ICK TOXIN PHI-XIBALBIN3- REMARK 900 XT3A DBREF 7RZ3 A 1 82 PDB 7RZ3 7RZ3 1 82 SEQRES 1 A 82 SER ALA VAL LEU TRP ASN GLN GLN TYR ASP LYS THR VAL SEQRES 2 A 82 CYS ASN GLN GLU GLY GLU PHE CYS SER LYS SER GLY VAL SEQRES 3 A 82 ASP CYS CYS ALA GLY LEU SER CYS ARG LYS TYR ASN LEU SEQRES 4 A 82 MET GLY TYR GLY VAL CYS ALA ALA GLN THR CYS SER GLU SEQRES 5 A 82 GLU GLY THR PHE CYS SER LEU SER ASP SER ASP CYS CYS SEQRES 6 A 82 SER GLY LEU LYS CYS LYS ARG ARG GLY HIS GLY TYR GLY SEQRES 7 A 82 GLU CYS SER LYS SHEET 1 AA1 3 PHE A 56 CYS A 57 0 SHEET 2 AA1 3 GLY A 78 GLU A 79 -1 O GLY A 78 N CYS A 57 SHEET 3 AA1 3 LYS A 71 ARG A 72 -1 N LYS A 71 O GLU A 79 SSBOND 1 CYS A 14 CYS A 29 1555 1555 2.00 SSBOND 2 CYS A 21 CYS A 34 1555 1555 2.00 SSBOND 3 CYS A 28 CYS A 45 1555 1555 2.10 SSBOND 4 CYS A 50 CYS A 65 1555 1555 2.00 SSBOND 5 CYS A 57 CYS A 70 1555 1555 2.00 SSBOND 6 CYS A 64 CYS A 80 1555 1555 2.00 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1